Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

No association between glutathione-synthesis-related genes and Japanese schizophrenia.

Hanzawa R, Ohnuma T, Nagai Y, Shibata N, Maeshima H, Baba H, Hatano T, Takebayashi Y, Hotta Y, Kitazawa M, Arai H.

Psychiatry Clin Neurosci. 2011 Feb;65(1):39-46. doi: 10.1111/j.1440-1819.2010.02157.x. Epub 2010 Nov 24.

2.

Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia.

Butticaz C, Werge T, Beckmann JS, Cuénod M, Do KQ, Rivolta C.

Psychiatr Genet. 2009 Aug;19(4):201-8. doi: 10.1097/YPG.0b013e32832cef21.

PMID:
19455074
3.

Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.

Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, Iwata N.

Ann N Y Acad Sci. 2008 Oct;1139:63-9. doi: 10.1196/annals.1432.022.

PMID:
18991850
4.

Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia.

Gysin R, Kraftsik R, Boulat O, Bovet P, Conus P, Comte-Krieger E, Polari A, Steullet P, Preisig M, Teichmann T, Cuénod M, Do KQ.

Antioxid Redox Signal. 2011 Oct 1;15(7):2003-10. doi: 10.1089/ars.2010.3463. Epub 2010 Oct 30.

PMID:
20673128
5.
6.

Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population.

Matsuzawa D, Hashimoto K, Hashimoto T, Shimizu E, Watanabe H, Fujita Y, Iyo M.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):86-94. doi: 10.1002/ajmg.b.30776.

PMID:
18449862
7.

Skin fibroblast model to study an impaired glutathione synthesis: consequences of a genetic polymorphism on the proteome.

Gysin R, Riederer IM, Cuénod M, Do KQ, Riederer BM.

Brain Res Bull. 2009 Apr 6;79(1):46-52. doi: 10.1016/j.brainresbull.2008.10.015. Epub 2008 Nov 28.

PMID:
19041695
8.

Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response.

Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP.

J Biol Chem. 2002 Dec 20;277(51):49446-52. Epub 2002 Oct 15.

9.

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.

Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, Tosic M, Werge T, Cuénod M, Do KQ.

Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16621-6. Epub 2007 Oct 5.

10.

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.

Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey ML, Parnas J, Preisig M, Saraga M, Solida A, Timm S, Wang AG, Werge T, Cuénod M, Do KQ.

Am J Hum Genet. 2006 Sep;79(3):586-92. Epub 2006 Jul 31.

11.

Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.

Arai S, Shibata H, Sakai M, Ninomiya H, Iwata N, Ozaki N, Fukumaki Y.

Psychiatr Genet. 2009 Feb;19(1):6-13. doi: 10.1097/YPG.0b013e328311875d.

PMID:
19125103
12.

Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder.

Kulak A, Cuenod M, Do KQ.

Behav Brain Res. 2012 Jan 15;226(2):563-70. doi: 10.1016/j.bbr.2011.10.020. Epub 2011 Oct 20.

PMID:
22033334
13.

Glutamate cysteine ligase catalysis: dependence on ATP and modifier subunit for regulation of tissue glutathione levels.

Chen Y, Shertzer HG, Schneider SN, Nebert DW, Dalton TP.

J Biol Chem. 2005 Oct 7;280(40):33766-74. Epub 2005 Aug 4.

14.

Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT.

Berk M, Johansson S, Wray NR, Williams L, Olsson C, Haavik J, Bjerkeset O.

J Affect Disord. 2011 Jun;131(1-3):207-13. doi: 10.1016/j.jad.2010.12.019. Epub 2011 Jan 31.

PMID:
21277635
15.

Linkage disequilibrium in aquaporin 4 gene and association study with schizophrenia.

Muratake T, Fukui N, Kaneko N, Amagane H, Someya T.

Psychiatry Clin Neurosci. 2005 Oct;59(5):595-8.

16.

Assessing oxidative pathway genes as risk factors for bipolar disorder.

Fullerton JM, Tiwari Y, Agahi G, Heath A, Berk M, Mitchell PB, Schofield PR.

Bipolar Disord. 2010 Aug;12(5):550-6. doi: 10.1111/j.1399-5618.2010.00834.x.

PMID:
20712757
17.

Association and expression studies of glutamate-cysteine ligase modifier (GCLM) and schizophrenia in the Chinese Han population.

Che R, Tang W, Shao L, Zhao Q, Huang K, Tang R, Li Z, Zhao X, Ji W, Zhou G, Feng G, He L, Shi Y.

Psychiatr Genet. 2009 Oct;19(5):279-80. doi: 10.1097/YPG.0b013e32832cec76. No abstract available.

PMID:
19584774
18.

Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region.

Makino C, Fujii Y, Kikuta R, Hirata N, Tani A, Shibata A, Ninomiya H, Tashiro N, Shibata H, Fukumaki Y.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):17-22.

PMID:
12497607
19.

Variable regulation of glutamate cysteine ligase subunit proteins affects glutathione biosynthesis in response to oxidative stress.

Krzywanski DM, Dickinson DA, Iles KE, Wigley AF, Franklin CC, Liu RM, Kavanagh TJ, Forman HJ.

Arch Biochem Biophys. 2004 Mar 1;423(1):116-25.

PMID:
14871475
20.

Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.

Shibata H, Tani A, Chikuhara T, Kikuta R, Sakai M, Ninomiya H, Tashiro N, Iwata N, Ozaki N, Fukumaki Y.

Psychiatry Res. 2009 May 15;167(1-2):88-96. doi: 10.1016/j.psychres.2007.12.002. Epub 2009 Apr 7.

PMID:
19351574

Supplemental Content

Support Center